This session will examine disparities in HIV prevention and transmission among Black/African American cisgender women and discuss effective strategies and approaches to prescribing pre-exposure prophylaxis (PrEP).

Learning Objectives:

• Describe disparities in HIV prevention and transmission among Black and African/American cisgender women.
• Review pre-prescription screening and FDA-approved options for HIV PrEP.
• Discuss best practices for patient monitoring and clinical management.